Deans' stroke musings

Changing stroke rehab and research worldwide now.Time is Brain!Just think of all the trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 493 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It's quite disgusting that this information is not available from every stroke association and doctors group.
My back ground story is here:http://oc1dean.blogspot.com/2010/11/my-background-story_8.html

Sunday, November 6, 2016

Cloud-based imaging software cleared by FDA to assist in blood flow analysis

This is cardiac not cerebral so our great stroke association needs to run some followup research for our use. But that won't occur with our fucking failures of stroke associations. Because if we know what blood flow problems there are we could use the arteriogenesis and angiogenesis protocols to creates better blood flow.
http://www.healio.com/cardiology/imaging/news/online/%7Bdf1f5ba0-5f15-43f7-8b87-e28f390184dc%7D/cloud-based-imaging-software-cleared-by-fda-to-assist-in-blood-flow-analysis?utm_source=maestro&utm_medium=email&utm_campaign=cardiology%20news

Arterys announced that its cloud-based medical imaging software has been cleared by the FDA to be used for quantification of cardiac flow in clinical settings.

The system (Arterys Software) includes 4D flow and 2D phase contrast workflows, as well as cardiac function measurements, according to a press release from the company, which also stated that the system was previously cleared to provide 4D flow visualization.
The software program can analyze blood flow to the heart and vessels via multislice, multiphase and velocity-coated 4D MRIs, and has been validated with images taken from 1.5-Tesla and 3-T MRI scanners, according to the release.
The system can be used to assist clinical decision making for patients with complex congenital heart disease, shunts and collateral vessels, aortic disease and valvular disease, the company stated in the release.

No comments:

Post a Comment